Introduction: The objective of this study was to assess family history links between breast cancer and prostate cancer in a prospectively collected cohort from the Prostate, Lung, Colorectal, and Ovary (PLCO) trial.
Patients And Methods: This is a secondary analysis of the PLCO trial datasets. Eligible patients included female participants with complete information about prostate cancer family history and male participants with complete information about breast cancer family history. Multivariate Cox regression analysis was used to assess the impact of prostate cancer family history on breast cancer incidence and mortality. Likewise, multivariate Cox regression analysis was used to assess the impact of breast cancer family history on prostate cancer incidence and mortality.
Results: A total of 45,807 female participants were eligible and included in the current study, and a total of 43,009 male participants were eligible and included in the current analysis. Within a multivariate Cox regression analysis, prostate cancer family history in a first-degree relative (FDR) was associated with a higher probability of diagnosis of breast cancer (hazard ratio [HR], 1.128; 95% confidence interval [CI], 1.007-1.265; P = .038); whereas it was not associated with a higher risk of death from breast cancer (HR, 1.065; 95% CI, 0.668-1.698; P = .791). Similarly, within a multivariate Cox regression analysis, breast cancer family history in an FDR was associated with a higher probability of diagnosis of prostate cancer (HR, 1.092; 95% CI, 1.011-1.180; P = .026) but not death from prostate cancer (HR, 0.442; 95% CI, 0.137-1.432; P = .173).
Conclusions: Female participants with a family history of prostate cancer in an FDR were more likely to develop postmenopausal breast cancer. Likewise, male participants with a family history of breast cancer in an FDR are at a higher probability of prostate cancer development. Risk correlation for premenopausal breast cancer could not be assessed owing to the nature of the PLCO study.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.clbc.2020.03.005 | DOI Listing |
J Am Coll Radiol
December 2024
Vice Chair for Radiology, Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts; Co-Chair, RSNA Health Equity Committee; Associate Editor, Journal of the American College of Radiology.
Purpose: The aim of this study was to assess how pandemic-related health concerns and discrimination affected cancer screenings among Asian American women (AAW).
Methods: A two-phase explanatory mixed-methods study was conducted. In phase 1, a survey was distributed among AAW eligible for lung, breast, or colorectal cancer screening to assess delays during the pandemic, concerns about contracting coronavirus disease 2019 (COVID-19), barriers to care, and experiences of discrimination.
Psychiatry Clin Psychopharmacol
December 2024
Department of Operating Room, the Fifth Affiliated Hospital of Wenzhou Medical University, Lishui Central Hospital, Lishui, China.
Background: Patients with unilateral breast loss after single mastectomy for breast cancer may have body image disorders such as surgical lymphedema, flap ischemia, and spinal deformity, resulting in negative emotions such as depression, inferiority, and social dysfunction. This study mainly investigated and analyzed the status quo and influencing factors of body image disorder in breast cancer patients after single mastectomy.
Methods: This study is a cross-sectional study.
Sensors (Basel)
December 2024
Department of Systems Design Engineering, University of Waterloo, Waterloo, ON N2L 3G1, Canada.
Breast cancer is a significant cause of death from cancer in women globally, highlighting the need for improved diagnostic imaging to enhance patient outcomes. Accurate tumor identification is essential for diagnosis, treatment, and monitoring, emphasizing the importance of advanced imaging technologies that provide detailed views of tumor characteristics and disease. Recently, a new imaging modality named synthetic correlated diffusion imaging (CDI) has been showing promise for enhanced prostate cancer delineation when compared to existing MRI imaging modalities.
View Article and Find Full Text PDFSensors (Basel)
December 2024
Research Department of Imaging Physics and Engineering, School of Biomedical Engineering and Imaging Sciences, King's College London, London WC2R 2LS, UK.
MR elastography is a non-invasive imaging technique that provides quantitative maps of tissue biomechanical properties, i.e., elasticity and viscosity.
View Article and Find Full Text PDFPharmaceutics
December 2024
Laboratory of Genetics and Biotechnology, Institute of Biotechnology, Federal University of Uberlândia, Patos de Minas 38700-002, MG, Brazil.
: Triple-negative breast cancer (TNBC) is the most challenging molecular subtype of breast cancer (BC) in clinical practice, associated with a worse prognosis due to limited treatment strategies and its insensitivity to conventional drugs. Zinc is an important trace element for homeostasis, and its Schiff base metal complexes have shown promise in treating advanced tumors. In this study, four new heteroleptic Zn(II) complexes (-) with Schiff bases were synthesized, characterized, and evaluated for their activity in BC cells.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!